Sutro Biopharma STRO Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Sutro Biopharma in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sutro Biopharma's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sutro Biopharma's short-term investments?
- Sutro Biopharma (STRO) reported short-term investments of $128.88M in Q1 2026.
- How has Sutro Biopharma's short-term investments changed year-over-year?
- Sutro Biopharma's short-term investments decreased by 9.7% year-over-year, from $142.74M to $128.88M.
- What is the long-term trend for Sutro Biopharma's short-term investments?
- Over 5 years (2020 to 2025), Sutro Biopharma's short-term investments has grown at a -7.1% compound annual growth rate (CAGR), from $120.34M to $83.3M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.